2019
Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study
Goedel WC, King MRF, Lurie MN, Galea S, Townsend JP, Galvani AP, Friedman SR, Marshall BDL. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study. Clinical Infectious Diseases 2019, 70: 1096-1102. PMID: 31143944, PMCID: PMC7319062, DOI: 10.1093/cid/ciz321.Peer-Reviewed Original ResearchConceptsSyringe services programHuman immunodeficiency virusHuman immunodeficiency virus (HIV) transmissionMore HIV infectionsInjection drug useHarm reduction servicesRural countiesScott CountyHIV infectionHIV transmissionImmunodeficiency virusDecrease incidenceHIV outbreakIncidence rateFirst infectionEarly infectionDrug useSingle infectionInfectionIncidenceVirus transmissionPWIDService programsDrugsTimely implementation
2015
The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States
Durham DP, Skrip LA, Bruce RD, Vilarinho S, Elbasha EH, Galvani AP, Townsend JP. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States. Clinical Infectious Diseases 2015, 62: 298-304. PMID: 26628566, PMCID: PMC4706637, DOI: 10.1093/cid/civ894.Peer-Reviewed Original ResearchConceptsHepatitis C virusInterferon-free DAAsHCV incidenceTreatment ratesChronic hepatitis C virusCases of cirrhosisInjection drug useImpact of administrationAnnual treatment ratesEnhanced screeningHCV prevalenceHCV screeningDecompensated cirrhosisHCV infectionHCV transmissionHepatitis CLiver transplantActing antiviralsLevels of screeningPatients 4C virusHepatocellular carcinomaEpidemiological dataUniversal screeningDrug use